Eran Seger
Chief Executive Officer & Co-Founder Protai
Eran Seger is an experienced technology executive and entrepreneur. He is the Founder and CEO of Protai, an AI-powered pharmaceutical company that leverages advanced structural proteomics and artificial intelligence to transform how induced proximity drugs are discovered.
Seminars
Tuesday 27th October 2026
Panel Discussion: Harnessing Rational Design and Structural Insights to Develop Induced Proximity Molecules with Enhanced Translational Potential
2:40 pm
- Transforming molecular glue discovery with structure-guided design, novel platforms and emerging tools
- Employing AI for degrader design to enable modelling and informed development
- Strategizing the future of induced proximity through rational, predictive design
Thursday 29th October 2026
Discussion: Harnessing AI & Computational Modelling to Optimize Design, Specificity & Efficacy of Induced Proximity Molecules to Support the Development of Tolerable, Selective Therapies
10:00 am
- Optimizing PROTAC linkers & E3 ligase pairing with AI and machine learning tools for enhanced selectivity and potency
- Transforming molecular glue design with AI to predict target engagement, enhance selectivity and minimize off-target degradation
- Employing computational tools and modelling approaches to inform therapeutic strategy across induced proximity modalities
